Pregnant Human Myometrial 1-41 Cell Viability Test on Vitamin D Administration

Muhammad Alamsyah Aziz, Sofie Rifayani Krisnadi, Budi Handono, Budi Setiabudiawan

Abstract


Background: Preterm labor is one of the universal causes of perinatal mortality worldwide. One of the causes of preterm labor is uterine muscle integrity problems. Some mechanistic studies show insight into vitamin D activity’s possible role in the injured muscle. This study aimed to determine whether vitamin D can increase muscle cell viability.

Methods: This experimental research used human smooth muscle uterine myometrium cell line pregnant human myometrial (PHM) 1-41. The cells were cultured for 24 hours in hypoxia condition, then incubated with several doses of vitamin D. The PHM1-41 cell viability was measured using spectrophotometry. Data analysis was conducted using IBM SPSS 24.0. A p-value <0.05 was considered statistically significant.

Results: The result showed that the minimum level of muscle cell viability after vitamin D incubation was with 300 nM administration, and the maximum level was after 10nM (88.57%+4.48 and 96.21%+2.13 respectively).

Conclusions: Vitamin D at a specific dose can improve cell availability. The optimal dose to improve cell viability is 10 nM.

 


Keywords


Oxidative stress, PHM1-41 cell viability, preterm labor, vitamin D

Full Text:

PDF

References


  1. interventions to improve preterm birth outcomes. Geneva: WHO; 2015.
  2. Blencowe H, Cousens S, Oestergaard M, Chou D, Moller AB, Narwal R, et al. National, regional and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–72.
  3. Rahmawaty S, Prawesti A, Fatimah S. Pengaruh nesting terhadap saturasi oksigen dan berat badan pada bayi prematur di Ruang Perinatologi RSUP Dr. Hasan Sadikin Bandung. J Keperawatan Aisyiyah. 2017;4(2):1–8.
  4. Wadhwa PD, Entringer S, Buss C, Lu MC. The contribution of maternal stress to preterm birth: issues and considerations. Clin Perinatol. 2011;38(3):351–84.
  5. Wagner CL, Taylor SN, Johnson DD, Hollis BW. The role of vitamin D in pregnancy and lactation: emerging concepts. Womens Health (Lond). 2012;8(3):323–40.
  6. Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, et al. Vitamin D: beyond bone. Ann N Y Acad Sci. 2013;1287(1):45–58.
  7. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33(3):456–92.
  8. Gernand AD, Klebanoff MA, Simhan HN, Bodnar LM. Maternal vitamin D status, prolonged labor, cesarean delivery and instrumental delivery in an era with a low cesarean rate. J Perinatol. 2015;35(1):23–28.
  9. Latham CM, Brightwell CR, Keeble AR, Munson BD, Thomas NT, Zagzoog AM, et al. Vitamin D promotes skeletal muscle regeneration and mitochondrial health. Front Physiol. 2021;12:660498.
  10. Dawson-Hughes B. Vitamin D and muscle function. J Steroid Biochem Mol Biol. 2017;173:313–6.
  11. Chung C, Silwal P, Kim I, Modlin RL, Jo E-K. Vitamin D-cathelicidin axis: at the crossroads between protective immunity and pathological inflammation during infection. Immune Netw. 2020;20(2):e12.
  12. Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207–18.
  13. Sepidarkish M, Farsi F, Akbari-Fakhrabadi M, Namazi N, Almasi-Hashiani A, Hagiagha AM, et al. The effect of vitamin D supplementation on oxidative stress parameters: a systematic review and meta-analysis of clinical trials. Pharmacol Res. 2019;139:141–52.
  14. Wimalawansa SJ. Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology (Basel). 2019;8(2):30.
  15. Aziz MA, Krisnadi SR, Setiabudiawan B, Handono B. Effect of vitamin D3 treatment on genes expression of corticotrophin releasing hormone (CRH), CRH receptor 1 (CRH-R1) and connexin-43 (CON-43) in PHM1-41 cell line that induced by hypoxia. Trends Sci. 2022;19(20):6236.
  16. Bhoora S, Pather Y, Marais S, Punchoo R. Cholecalciferol inhibits cell growth and induces apoptosis in the CaSki cell line. Med Sci (Basel). 2020;8(1):12.
  17. Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat. 2003;80(1):49–62.
  18. Fleet JC, Desmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441(1):61–76.
  19. Leal LKAM, Lima LA, de Aquino PEA, de Sousa JAC, Gadelha CVJ, Calou IBF, et al. Vitamin D (VD3) antioxidative and anti-inflammatory activities: peripheral and central effects. Eur J Pharmacol. 2020;879:173099.
  20. Mateen S, Moin S, Shahzad S, Khan AQ. Level of inflammatory cytokines in rheumatoid arthritis patients: correlation with 25-hydroxy vitamin D and reactive oxygen species. PLoS One. 2017;12(6):e0178879.




DOI: https://doi.org/10.15850/amj.v10n3.2750

Article Metrics

Abstract view : 206 times
PDF - 100 times



 This Journal indexed by

                  

          

 

Creative Commons License
AMJ is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats